Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Target Corp. recently backed Inspectorio, a technology startup focused on improving supply chain visibility and quality control, reports StarTribune.
Few people sign up and participate in clinical trials, and those who do don't always represent the entire U.S. population. Since a specific population can be more at risk for a certain disease, it's important this population is represented in…
Jim O'Neill, managing director at Silicon Valley investment company Mithril Capital Management, has been under consideration to head the Food and Drug Administration since early December. On Thursday, Balaji Srinivasan's name surfaced as a potential new candidate for the position,…
While president-elect Donald Trump called for the return of drug production to the U.S. as a strategy to lower drug prices during his Wednesday press conference, some experts say any move to limit drug imports could actually raise prices, reports the…
The success of any supply chain largely depends on the cooperation and collaboration of all stakeholders — whether they work in the same building or halfway around the world, according to Bill DuBois, director of marketing content for Kinaxis.
The University of Michigan's business school updated its supply chain management program to better reflect the needs of the industry, reports Crain's Detroit Business.
FedEx will offer customers the opportunity to pickup or drop off packages at almost 8,000 Walgreens locations nationwide.
Heart disease and strokes kill more than 786,000 Americans each year, according to the American Heart Association. With such a massive need for more treatment options, medical device makers are rolling out new cardiac devices and merging with other companies…
While anxiety and depression rates are rising throughout the world, experts say new antidepressants won't hit the market for at least 10 years, reports Reuters.
Drugstore chain CVS disclosed Thursday that it will sell a rival, generic version of Mylan's EpiPen for about one-sixth of the price, according to CNN Money.